Overuse of medication as risk factor of chronic headache

被引:0
|
作者
Katsarava, Z. [1 ]
Zwarg, T. [1 ]
Wallasch, T. -M. [2 ]
机构
[1] Univ Klinikum Essen, Neurol Klin, D-45122 Essen, Germany
[2] Lehrkrankenhaus Charite, Sankt Gertrauden Krankenhaus Berlin, Klin Interdisziplinare Schmerztherapie, Kopf Schmerzzentrum, Berlin, Germany
关键词
Medication overuse; chronic headache; migraine; tension-type headache; SEROTONIN SYNTHESIS; WITHDRAWAL; SUMATRIPTAN; CAFFEINE; FEATURES; THERAPY; ABUSE; ZOLMITRIPTAN; ANALGESICS; PREDICTORS;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The international headache society defines headache as chronic if it occurs on more than 15 days per month. The vast majority of patients suffering from chronic headache have medication overuse headache, chronic migraine or chronic tension-type headache. Frequent intake (overuse) of acute headache drugs is probably the most important risk factor leading do the development of medication overuse headache (MOH). The prevalence of MOH reaches approximately 1% of the world's population and shows an increasing trend. Many important studies on medication overuse headache have been published. Some of them investigated the pathophysiology of headache chronification others focused on the evaluation of risk factors. The IHS revised its classification criteria on MOH. Several large population based longitudinal studies clearly demonstrated that overuse of any kind of acute headache medication is the main risk factor leading to the development of chronic headache. Management of MOH remains difficult. The only effective treatment concept remains consequent withdrawal therapy.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 50 条
  • [41] Breaking the cycle of medication overuse headache
    Crain, Allison
    JOURNAL OF FAMILY PRACTICE, 2021, 70 (01) : 20 - 28
  • [42] Rebound-withdrawal headache (medication overuse headache)
    Couch Jr. J.R.
    Current Treatment Options in Neurology, 2006, 8 (1) : 11 - 19
  • [43] Medication Overuse Headache in Children and Adolescents
    Chiappedi, Matteo
    Balottin, Umberto
    CURRENT PAIN AND HEADACHE REPORTS, 2014, 18 (04)
  • [44] Controversy over the Classification of Medication-Overuse Headache
    Vincent, Maurice B.
    CURRENT PAIN AND HEADACHE REPORTS, 2012, 16 (01) : 80 - 85
  • [45] Medication-overuse headache: where are we now?
    Katsarava, Zaza
    Jensen, Rigmor
    CURRENT OPINION IN NEUROLOGY, 2007, 20 (03) : 326 - 330
  • [46] The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
    Martelletti, Paolo
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [47] Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse
    Maria Lurenda Westergaard
    Ebba Holme Hansen
    Charlotte Glümer
    Rigmor Højland Jensen
    European Journal of Clinical Pharmacology, 2015, 71 : 851 - 860
  • [48] Withdrawal failure in patients with chronic migraine and medication overuse headache
    D'Amico, Domenico
    Grazzi, Licia
    Guastafierro, Erika
    Sansone, Emanuela
    Leonardi, Matilde
    Raggi, Alberto
    ACTA NEUROLOGICA SCANDINAVICA, 2021, 144 (04): : 408 - 417
  • [49] Medication overuse headache: A focus on analgesics, ergot alkaloids and triptans
    Katsarawa Z.
    Diener H.
    Limmroth V.
    Drug Safety, 2001, 24 (12) : 921 - 927
  • [50] Evaluation of Relationship Between Childhood Maltreatment and Medication Overuse Headache
    Altintas, Ebru
    Goksel, Basak Karakurum
    Sariturk, Cagla
    Taskintuna, Nilgun
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2015, 52 (03): : 267 - 271